Page last updated: 2024-08-07 16:51:01
Oxysterols receptor LXR-beta
An oxysterols receptor LXR-beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55055]
Synonyms
Liver X receptor beta;
Nuclear receptor NER;
Nuclear receptor subfamily 1 group H member 2;
Ubiquitously-expressed nuclear receptor
Research
Bioassay Publications (58)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (32.76) | 29.6817 |
2010's | 36 (62.07) | 24.3611 |
2020's | 3 (5.17) | 2.80 |
Compounds (25)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drugs with Other Measurements
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 15, Issue:11, 2005
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.Journal of natural products, , Volume: 68, Issue:8, 2005
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists.Journal of medicinal chemistry, , 08-10, Volume: 60, Issue:15, 2017
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.Journal of natural products, , Volume: 68, Issue:8, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 15, Issue:11, 2005
Discovery of new LXRβ agonists as glioblastoma inhibitors.European journal of medicinal chemistry, , May-15, Volume: 194, 2020
Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 25, Issue:6, 2015
Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 25, Issue:13, 2015
Discovery of tertiary sulfonamides as potent liver X receptor antagonists.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 19, Issue:19, 2009
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 19, Issue:7, 2009
Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 19, Issue:4, 2009
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development.Bioorganic & medicinal chemistry, , Apr-15, Volume: 16, Issue:8, 2008
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.Journal of medicinal chemistry, , Sep-25, Volume: 51, Issue:18, 2008
Discovery and structure-activity relationship studies of indole derivatives as liver X receptor (LXR) agonists.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 17, Issue:12, 2007
2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.Bioorganic & medicinal chemistry letters, , Aug-15, Volume: 17, Issue:16, 2007
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.Journal of medicinal chemistry, , Aug-23, Volume: 50, Issue:17, 2007
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.Journal of medicinal chemistry, , Oct-19, Volume: 49, Issue:21, 2006
Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.Journal of medicinal chemistry, , Aug-25, Volume: 48, Issue:17, 2005
Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists.Bioorganic & medicinal chemistry, , 07-15, Volume: 66, 2022
Discovery of new LXRβ agonists as glioblastoma inhibitors.European journal of medicinal chemistry, , May-15, Volume: 194, 2020
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.Journal of medicinal chemistry, , 02-28, Volume: 62, Issue:4, 2019
Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool.MedChemComm, , Aug-01, Volume: 10, Issue:8, 2019
Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity.Bioorganic & medicinal chemistry letters, , 01-15, Volume: 28, Issue:2, 2018
Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.Bioorganic & medicinal chemistry letters, , 02-15, Volume: 28, Issue:4, 2018
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators.Bioorganic & medicinal chemistry letters, , 03-01, Volume: 27, Issue:5, 2017
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.Journal of medicinal chemistry, , Oct-13, Volume: 59, Issue:19, 2016
Identification and in Vivo Evaluation of Liver X Receptor β-Selective Agonists for the Potential Treatment of Alzheimer's Disease.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Altered activity profile of a tertiary silanol analog of multi-targeting nuclear receptor modulator T0901317.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 26, Issue:7, 2016
Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core.Bioorganic & medicinal chemistry letters, , 10-15, Volume: 26, Issue:20, 2016
Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist.Bioorganic & medicinal chemistry, , 08-15, Volume: 24, Issue:16, 2016
Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists.Bioorganic & medicinal chemistry letters, , Mar-15, Volume: 25, Issue:6, 2015
Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 25, Issue:2, 2015
Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.Bioorganic & medicinal chemistry letters, , Jul-01, Volume: 25, Issue:13, 2015
Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.ACS medicinal chemistry letters, , Aug-13, Volume: 6, Issue:8, 2015
Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 25, Issue:18, 2015
Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).Journal of medicinal chemistry, , Jul-24, Volume: 57, Issue:14, 2014
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 24, Issue:22, 2014
Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.Bioorganic & medicinal chemistry, , May-01, Volume: 22, Issue:9, 2014
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc.Bioorganic & medicinal chemistry letters, , Dec-15, Volume: 23, Issue:24, 2013
Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 23, Issue:14, 2013
Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 22, Issue:12, 2012
Discovery of a new binding mode for a series of liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 22, Issue:7, 2012
Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.Journal of medicinal chemistry, , Sep-13, Volume: 55, Issue:17, 2012
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.Journal of medicinal chemistry, , Feb-10, Volume: 54, Issue:3, 2011
1-(3-Aryloxyaryl)benzimidazole sulfones are liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonists.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 20, Issue:1, 2010
Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.Bioorganic & medicinal chemistry letters, , May-01, Volume: 20, Issue:9, 2010
3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.Journal of medicinal chemistry, , Apr-22, Volume: 53, Issue:8, 2010
4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.Bioorganic & medicinal chemistry, , Dec-01, Volume: 17, Issue:23, 2009
Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.Bioorganic & medicinal chemistry, , May-15, Volume: 17, Issue:10, 2009
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 19, Issue:7, 2009
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development.Bioorganic & medicinal chemistry, , Apr-15, Volume: 16, Issue:8, 2008
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 18, Issue:1, 2008
Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.Journal of medicinal chemistry, , Sep-25, Volume: 51, Issue:18, 2008
Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.Bioorganic & medicinal chemistry, , Mar-01, Volume: 15, Issue:5, 2007
Discovery and structure-activity relationship studies of indole derivatives as liver X receptor (LXR) agonists.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 17, Issue:12, 2007
2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.Bioorganic & medicinal chemistry letters, , Aug-15, Volume: 17, Issue:16, 2007
Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRalpha and beta.Bioorganic & medicinal chemistry letters, , Oct-01, Volume: 16, Issue:19, 2006
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.Journal of medicinal chemistry, , Oct-19, Volume: 49, Issue:21, 2006
Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.Journal of medicinal chemistry, , Aug-25, Volume: 48, Issue:17, 2005
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.Journal of medicinal chemistry, , Apr-14, Volume: 59, Issue:7, 2016
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 19, Issue:7, 2009
SAR studies: designing potent and selective LXR agonists.Bioorganic & medicinal chemistry letters, , Jun-01, Volume: 16, Issue:11, 2006
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.Journal of natural products, , Volume: 68, Issue:8, 2005
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.Bioorganic & medicinal chemistry letters, , Jun-02, Volume: 15, Issue:11, 2005
Discovery of new LXRβ agonists as glioblastoma inhibitors.European journal of medicinal chemistry, , May-15, Volume: 194, 2020
Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators.Bioorganic & medicinal chemistry letters, , 03-01, Volume: 27, Issue:5, 2017
Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 20, Issue:2, 2010
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.Journal of medicinal chemistry, , Nov-27, Volume: 51, Issue:22, 2008
Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors.European journal of medicinal chemistry, , Nov-15, Volume: 206, 2020
Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.European journal of medicinal chemistry, , Sep-15, Volume: 178, 2019
Recent Advances in the Medicinal Chemistry of Liver X Receptors.Journal of medicinal chemistry, , 12-27, Volume: 61, Issue:24, 2018
Enables
This protein enables 11 target(s):
Target | Category | Definition |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | molecular function | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. [GOC:txnOH-2018] |
DNA-binding transcription activator activity, RNA polymerase II-specific | molecular function | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. [GOC:aruk, GOC:txnOH-2018, PMID:20737563, PMID:27145859] |
DNA binding | molecular function | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). [GOC:dph, GOC:jl, GOC:tb, GOC:vw] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
chromatin DNA binding | molecular function | Binding to DNA that is assembled into chromatin. [GOC:mah] |
apolipoprotein A-I receptor binding | molecular function | Binding to an apolipoprotein A-I receptor. [GOC:BHF, GOC:rl] |
nuclear retinoid X receptor binding | molecular function | Binding to a nuclear retinoid X receptor. [GOC:ai] |
ATPase binding | molecular function | Binding to an ATPase, any enzyme that catalyzes the hydrolysis of ATP. [GOC:ai] |
nuclear receptor activity | molecular function | A DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytosol, which leads to its translocation to the nucleus. [GOC:txnOH-2018, PMID:23457262] |
Located In
This protein is located in 4 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
nucleoplasm | cellular component | That part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
Part Of
This protein is part of 2 target(s):
Target | Category | Definition |
RNA polymerase II transcription regulator complex | cellular component | A transcription factor complex that acts at a regulatory region of a gene transcribed by RNA polymerase II. [GOC:tb] |
chromatin | cellular component | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. [GOC:elh, PMID:20404130] |
Involved In
This protein is involved in 29 target(s):
Target | Category | Definition |
hormone-mediated signaling pathway | biological process | The series of molecular signals mediated by the detection of a hormone. [GOC:sm] |
negative regulation of macrophage derived foam cell differentiation | biological process | Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. [GOC:add, GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of triglyceride biosynthetic process | biological process | Any process that increases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol. [GOC:BHF, GOC:tb] |
positive regulation of cholesterol efflux | biological process | Any process that increases the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of lipid storage | biological process | Any process that increases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. [GOC:BHF, GOC:dph, GOC:tb] |
negative regulation of cholesterol storage | biological process | Any process that decreases the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. [GOC:BHF, GOC:dph, GOC:tb] |
intracellular receptor signaling pathway | biological process | The series of molecular signals initiated by a ligand binding to a receptor located within a cell. [GOC:bf, GOC:mah] |
negative regulation of lipid transport | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:mah] |
positive regulation of cholesterol transport | biological process | Any process that activates or increases the frequency, rate or extent of the directed movement of cholesterol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:mah] |
phosphatidylcholine acyl-chain remodeling | biological process | Remodeling the acyl chains of phosphatidylcholine, through sequential deacylation and re-acylation reactions, to generate phosphatidylcholine containing different types of fatty acid acyl chains. [GOC:mw, PMID:18195019, PMID:18458083] |
cholesterol homeostasis | biological process | Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell. [GOC:go_curators] |
mRNA transcription by RNA polymerase II | biological process | The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. [GOC:jl, ISBN:0321000382] |
positive regulation of fatty acid biosynthetic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids. [GOC:go_curators] |
negative regulation of proteolysis | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein. [GOC:go_curators] |
negative regulation of DNA-templated transcription | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of DNA-templated transcription | biological process | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH] |
positive regulation of transcription by RNA polymerase II | biological process | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. [GOC:go_curators, GOC:txnOH] |
negative regulation of pinocytosis | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of pinocytosis. Pinocytosis is the process in which cells take in liquid material from their external environment; literally 'cell drinking'. Liquid is enclosed in vesicles, formed by invagination of the plasma membrane. These vesicles then move into the cell and pass their contents to endosomes. [GOC:go_curators] |
positive regulation of lipoprotein lipase activity | biological process | Any process that activates or increases the activity of the enzyme lipoprotein lipase. [GOC:ai] |
positive regulation of protein metabolic process | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein. [GOC:ai] |
negative regulation of type II interferon-mediated signaling pathway | biological process | Any process that decreases the rate, frequency or extent of an interferon-gamma-mediated signaling pathway. [GOC:dph] |
positive regulation of high-density lipoprotein particle assembly | biological process | Any process that increases the frequency, rate, or extent of high-density lipoprotein particle assembly. High-density lipoprotein particle assembly is the aggregation and arrangement of proteins and lipids to form a high-density lipoprotein particle. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of pancreatic juice secretion | biological process | Any process that increases the rate, frequency or extent of pancreatic juice secretion, the regulated release of pancreatic juice by the exocrine pancreas into the upper part of the intestine. [GOC:BHF, GOC:dph, GOC:tb] |
positive regulation of secretion of lysosomal enzymes | biological process | Any process that increases the rate, frequency or extent of secretion of lysosomal enzymes, the controlled release of lysosomal enzymes by a cell. [GOC:BHF] |
negative regulation of cold-induced thermogenesis | biological process | Any process that stops, prevents, or reduces the rate of cold-induced thermogenesis. [PMID:27876809] |
positive regulation of miRNA transcription | biological process | Any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. [GO_REF:0000058, GOC:dph, GOC:kmv, GOC:TermGenie, PMID:24699545] |
negative regulation of response to endoplasmic reticulum stress | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of a response to endoplasmic reticulum stress. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:11381086] |
cell differentiation | biological process | The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. [ISBN:0198506732] |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |